Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Linking the KIR phenotype with STAT3 and TET2 mutations to identify chronic lymphoproliferative disorders of NK cells

Cédric Pastoret, Fabienne Desmots, Gaëlle Drillet, Simon Le Gallou, Marie-Laure Boulland, Alexia Thannberger, Anne-Violaine Doncker, Véronique Salaun, Gandhi Laurent Damaj, Richard Veyrat-Masson, Olivier Tournilhac, Aline Moignet, Céline Pangault, Mikaël Roussel, Thierry Fest, Thierry Lamy

Blood (2021) 137 (23): 3237–3250.

https://doi.org/10.1182/blood.2020006721

Published: 2021

Includes: Supplemental data

Journal Articles

BAFF and CD4 + T cells are major survival factors for long-lived splenic plasma cells in a B-cell–depletion context

Lan-Huong Thai, Simon Le Gallou, Ailsa Robbins, Etienne Crickx, Tatiana Fadeev, Zhicheng Zhou, Nicolas Cagnard, Jérôme Mégret, Christine Bole, Jean-Claude Weill, Claude-Agnès Reynaud, Matthieu Mahévas

Blood (2018) 131 (14): 1545–1555.

https://doi.org/10.1182/blood-2017-06-789578

Published: 2018

Includes: Supplemental data

Journal Articles

BAFF and CD4 T-Cells Are Major Survival Factors for Splenic Plasma Cells in B Cell Depletion Context: Implications for Autoimmune Diseases

Lan-Huong Thai, MD PhDstudent, Ailsa Robbins, Simon Le Gallou, PhD, Nicolas Cagnard, Jean-Claude Weill, Professor, Claude-Agnès Reynaud, PhD, Matthieu Mahevas, MD PhD

Blood (2016) 128 (22): 129.

https://doi.org/10.1182/blood.V128.22.129.129

Published: 2016

Journal Articles

Emergence of Long-Lived Autoreactive Plasma Cells in the Spleen of Primary Warm Auto-Immune Hemolytic Anemia Patients Treated with Rituximab

Matthieu Mahevas, MD PhD, Marc Michel, MD PhD, Benoit Vingert, Julien Moroch, David Boutboul, Sylvain Audia, MD, PhD, Julie Ripa, Nicolas Cagnard, Karin Tarte, PharmD, PhD, Simon le Gallou, Lan-huong Thai, France Noizat-Pirenne, MDPhD, Bertrand Godeau, MDPhD, Jean-Claude Weill, Claude-Agnès Reynaud

Blood (2014) 124 (21): 569.

https://doi.org/10.1182/blood.V124.21.569.569

Published: 2014

Journal Articles

Emergence of Long-Lived Autoreactive Plasma Cells in the Spleen of ITP Patients Treated with Rituximab

Matthieu Mahévas, Marc Michel, Pauline Patin, Francois Huetz, Marc Descatoire, Nicolas Cagnard, Christine Bole-Feysot, Medhi Khellaf, Lionel Galicier, MD, David Boutboul, Mikael Ebbo, Simon le Gallou, Olivier Fain, Olivier Lambotte, MD, PhD, Corinne Haouin, MD, Philippe Bierling, MD, Bertrand Godeau, MD, Jean-claude Weill, Claude-Agnès Reynaud

Blood (2012) 120 (21): 620.

https://doi.org/10.1182/blood.V120.21.620.620

Published: 2012

NARROW

Linking the KIR phenotype with STAT3 and TET2 mutations to identify chronic lymphoproliferative disorders of NK cells

BAFF and CD4 + T cells are major survival factors for long-lived splenic plasma cells in a B-cell–depletion context

BAFF and CD4 T-Cells Are Major Survival Factors for Splenic Plasma Cells in B Cell Depletion Context: Implications for Autoimmune Diseases

Emergence of Long-Lived Autoreactive Plasma Cells in the Spleen of Primary Warm Auto-Immune Hemolytic Anemia Patients Treated with Rituximab

Emergence of Long-Lived Autoreactive Plasma Cells in the Spleen of ITP Patients Treated with Rituximab

Email alerts

ASH Publications

American Society of Hematology

Linking the KIR phenotype with STAT3 and TET2 mutations to identify chronic lymphoproliferative disorders of NK cells

BAFF and CD4 + T cells are major survival factors for long-lived splenic plasma cells in a B-cell–depletion context

BAFF and CD4 T-Cells Are Major Survival Factors for Splenic Plasma Cells in B Cell Depletion Context: Implications for Autoimmune Diseases

Emergence of Long-Lived Autoreactive Plasma Cells in the Spleen of Primary Warm Auto-Immune Hemolytic Anemia Patients Treated with Rituximab

Emergence of Long-Lived Autoreactive Plasma Cells in the Spleen of ITP Patients Treated with Rituximab

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only